Cancer news and cancer widget

(Radiological Society of North America) Using high-resolution magnetic resonance imaging with a special vaginal coil, a technique to measure the movement of water within tissue, researchers may be able to identify cervical cancer in its early stages, according to a new study.

(Radiological Society of North America) Three-dimensional power Doppler ultrasound helps radiologists distinguish between malignant and benign breast masses, according to a new study.

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for cancer and serious viral infections, today announced that it has completed enrollment in the first stage of its Phase II trial evaluating a combination regimen of bavituximab with carboplatin and paclitaxel in patients with non-small cell lung cancer (NSCLC).

The Cure Our Children Foundation, a nonprofit charitable foundation dedicated to children, announced that the U.S. Food and Drug Administration (FDA) has approved the Orphan Drug Designation of the foundation's unique drug product for children with Ewing's Sarcoma cancer. The efforts to develop this drug were made possible by the generous volunteers and researchers in private industry and at two universities.

Researchers at Wake Forest University School of medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life. While studying the effect of post-menopausal dietary soy consumption on estrogen metabolism in cynomolgus monkeys, Latanya M. Scott, Ph.D., discovered that monkeys who had been given birth control earlier in life had a reduced amount of estrogen excreted in their urine.

We all know and love Jeff Probst as the host of the hit reality series Survivor, but how do you feel about him fronting a show about people who aren't...

Cougar Biotechnology, Inc. (NASDAQ:CGRB) today announced that results from an ongoing Phase II clinical trial of Cougar's investigational drug CB7630 (abiraterone acetate) were presented today at the Prostate cancer Foundation Scientific Retreat. The Prostate Cancer Foundation Scientific Retreat is currently taking place in Lake Tahoe, Nevada. The clinical trial of CB7630 was conducted at the University of Texas M.D.

Ann Keen, MP and Professor Mike Richards CBE will be at the forefront of the debate around the provision of teenage cancer services this weekend when they join 400 teenage cancer patients at Teenage Cancer Trust's conference: "Find Your Sense of Tumour".

The Federation of Medical Women of Canada (FMWC) is launching a Pap test campaign during Cervical cancer Awareness week October 27-31, 2008. Women who do not have a family doctor or gynecologist will be able to drop-in or book an appointment with participating doctors during this campaign. "Cervical cancer remains a significant problem," says Dr. Kathleen Gartke, FMWC President.

Canada continues to export asbestos to developing countries, despite limiting its use in Canada, write Dr. Amir Attaran, David Boyd and Dr. Matthew Stanbrook http://www.cmaj.ca/press/pg871.pdf on behalf of the CMAJ editorial team.